Kenman Gan, MD FRCSC
University of British Columbia
Participants should be aware of the following financial/non-financial relationship:
Care1 Telemedicine: Stock Shareholder (excluding mutual funds)
First, we review the definitions of and concepts behind big data, automation, and deep learning. Second, we introduce how these concepts are being applied to teleophthalmology. Third, we discuss how the lessons learned can be extrapolated to applications in other medical specialties.
Teleophthalmology offers a unique opportunity to implement digital concepts in healthcare, due to (1) the very high prevalence of ocular diseases such as diabetic retinopathy, macular degeneration, and glaucoma that can be evaluated with store-and-forward telemedicine; and (2) the worldwide shortage of eyecare professionals in both first world and developing countries.
We present Care1, one of the largest teleophthalmology programs in the world. Based in Western Canada, dozens of healthcare providers are connected to deliver over 10,000 patient interactions every year. Canada has a unique need for teleophthalmology due to an alarming shortage of eyecare professionals, and a population that is spread out over a very large geographic expanse.
In order to deliver the highest level of care to very large numbers of patients, telemedicine is combined with software to maximize the time efficiency for healthcare professionals, allowing each single provider to deliver care to many more patients.
Existing scientific literature on the software-led provision of medical care has performance rates that are not high enough to be universally accepted by most healthcare professionals. The primary reasons for this include the overly strict application of automated medical algorithms on one end of the spectrum, and the overgeneralized application of machine learning and neural networks at the other end.
We demonstrate outstanding acceptance rates among healthcare professionals in the software-led provision of eyecare, by utilizing a hybrid concept of both extremes, "Medically Architected Deep Learning". Automation is applied to frameworks of diagnosis and treatment, for which there should be no variation. Deep learning and neural networks are then applied to individual facets within the automated framework, allowing artificial intelligence to superimpose the more subjective and provider dependent aspects of medical care. The result is software that is able to make profound diagnostic and treatment recommendations that have very high rates of alignment with clinical decisions made by healthcare professionals. Healthcare professionals benefit from improved efficiency, as it allows them to deliver much greater quality of care to a much larger number of patients. Clinical impact is exponential when these software benefits are applied to telemedicine networks.
The unique nature of ocular disease means that teleophthalmology is the ideal launching point into healthcare, for the most exciting and important technological concepts of the digital age.
University of British Columbia
Dr. Kenman Gan was born and raised in Edmonton, Alberta. He completed his Bachelors of Medical Science, Doctor of Medicine, and Ophthalmology specialization at the University of Alberta. During his training, he received many awards, including the Dr. T Alistair Boyd Prize in Ophthalmology, the John Proskie Memorial Scholarship in Ophthalmology, and the Reg Martiniuk Ophthalmology Award. Dual-licensed in both Alberta and British Columbia, Dr. Gan works between both provinces.
Dr. Gan graduated from Ophthalmology scoring 99 percentile out of all graduating ophthalmologists around the world writing the Ophthalmic Knowledge Assessment Program (OKAP) standardized examination. He has a strong interest in public health and collaborative eyecare, and is Medical Director of the Care1 Telemedicine Network. Care1 partners optometrists and ophthalmologists to provide over 10,000 consultations every year, and is the largest full-scope teleglaucoma program in the world.
Dr. Gan is also a laser eye surgeon with vast experience with both LASIK and PRK on a variety of platforms, including the Abbott Medical Optics IntraLase femtosecond laser, the Alcon Wavelight Allegretto Eye Q, and the Bausch and Lomb Z100. He is one of only three surgeons in British Columbia specialized in Topography-guided Custom Ablation Treatment (TCAT or T-PRK) and Corneal Collagen Cross-Linking (CXL or C3R) for treating patients with keratoconus and corneal ectasia.
Sunday, April 23
10:55 AM – 11:15 AM